GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy
Acta Diabetologica · 16.05.2026 · 63 (7) · 1265-1266
DOI: 10.1007/s00592-026-02708-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Acta Diabetologica, online erschienen am 16.05.2026. Verfasst von Sergio Maimone und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Taormina's Hospital, Messina, Italy. sergio.maimone@asp.messina.it. Die Arbeit nennt 5 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Taormina's Hospital, Messina, Italy. sergio.maimone@asp.messina.it.
- Fondazione Epatocentro Ticino, Lugano, Switzerland.
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
- IRCCS ISMETT, Palermo, Italy.
- UPMC Italy, Palermo, Italy.
- Internal Medicine, Taormina's Hospital, Messina, Italy.
Zitieren
APA
Maimone, S., Galante, A., Castoro, C., Scarcella, C., & Rapisarda, V. L. (2026). GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy. Acta Diabetologica, 63(7), 1265-1266. https://doi.org/10.1007/s00592-026-02708-2
Vancouver
Maimone S, Galante A, Castoro C, Scarcella C, Rapisarda VL. GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy. Acta Diabetologica. 2026;63(7):1265-1266. doi:10.1007/s00592-026-02708-2
BibTeX
@article{Maimone2026,
author = {Maimone, Sergio and Galante, Antonio and Castoro, Carlotta and Scarcella, Claudia and Rapisarda, Valentina Lucia},
title = {GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {7},
pages = {1265--1266},
doi = {10.1007/s00592-026-02708-2}
}
EUVIMED